Stocks · News reference
Citizens Upgrades RXO to Market Outperform, Announces $30 Price Target
Citizens analyst Jeff Kauffman upgrades RXO (NYSE:RXO) from Market Perform to Market Outperform and announces $30 price target.
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Aug 7, 2026, 3:18 PM
- Checked
- Aug 7, 2026, 3:18 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
UBS Maintains Neutral on RXO, Lowers Price Target to $23
UBS analyst Thomas Wadewitz maintains RXO (NYSE:RXO) with a Neutral and lowers the price target from $26 to $23.
Read original at benzingaTD Cowen Maintains Sell on RXO, Lowers Price Target to $17.5
TD Cowen analyst Jason Seidl maintains RXO (NYSE:RXO) with a Sell and lowers the price target from $19 to $17.5.
Read original at benzingaCitigroup Maintains Neutral on RXO, Lowers Price Target to $23
Citigroup analyst Ariel Rosa maintains RXO (NYSE:RXO) with a Neutral and lowers the price target from $30 to $23.
Read original at benzinga